Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19.
Fatema Tuz ZahraLorenza BellusciGabrielle GrubbsHana GoldingSurender KhuranaPublished in: Annals of the rheumatic diseases (2022)